AnaptysBio Overview
AnaptysBio Target Price
Analysts' 12-month price predictions for ANAB.
Share Price
$21.9
Average Target Price
$54.00
146.6% upside
146.6% upside1 analysts in the last 4 months
High: $54 | Low: $54
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-06 | GuggenheimYatin Suneja | $54 | 146.6% upside |  |
| 2025-03-03 | Guggenheim | $52 | 137.4% upside | |
| 2025-02-04 | Wolfe ResearchAndy Chen | $25 | 14.2% upside | |
| 2024-12-11 | H.C. WainwrightEmily Bodnar | $19 |  13.2% downside | |
| 2024-11-06 | H.C. WainwrightEmily Bodnar | $52 | 137.4% upside | |
| 2024-11-06 | Leerink PartnersDavid Risinger | $45 | 105.5% upside | |
| 2024-10-21 | GuggenheimYatin Suneja | $90 | 311% upside | |
| 2024-10-15 | Piper SandlerYasmeen Rahimi | $80 | 265.3% upside | |
| 2024-10-03 | New StreetDavid Risinger | $35 | 59.8% upside | |
| 2024-08-15 | Truist FinancialJoon Lee | $30 | 37% upside | |
| 2024-04-16 | Leerink PartnersDavid Risinger | $47 | 114.6% upside | |
| 2022-11-18 | J.P. Morgan | $32 | 46.1% upside | |